Yoseph Shaaltiel
Overview
Yoseph Shaaltiel received an average of $606K in total compensation, including $263K in salary, at Protalix BioTherapeutics from 2006 to 2019.
2019Protalix BioTherapeuticsExecutive Vice President, Research and Development
2018Protalix BioTherapeuticsExecutive Vice President, Research and Development
2017Protalix BioTherapeuticsExecutive Vice President, Research and Development
2016Protalix BioTherapeuticsExecutive Vice President, Research and Development
2015Protalix BioTherapeuticsExecutive Vice President, Research and Development
2014Protalix BioTherapeuticsExecutive Vice President, Research and Development
2013Protalix BioTherapeuticsExecutive Vice President, Research and Development
2012Protalix BioTherapeuticsExecutive Vice President, Research and Development
2011Protalix BioTherapeuticsExecutive Vice President, Research and Development
2010Protalix BioTherapeuticsExecutive Vice President, Research and Development
Source: SEC filings on April 15, 2020, April 12, 2019, March 6, 2018, March 16, 2017, July 1, 2016, October 9, 2014, September 19, 2013, May 21, 2012, September 19, 2011, September 17, 2009, and October 3, 2008.
Related executives
We found ten more executives who work or worked at Protalix BioTherapeutics.
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
Eyal Rubin
Protalix BioTherapeutics
Chief Financial Officer
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Chief Development Officer
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
David Aviezer
Protalix BioTherapeutics